Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives

被引:17
作者
Zhang, Zhenfa [1 ,2 ]
Yu, Aizhen [2 ]
Zhou, Weicheng [2 ]
机构
[1] Univ Kentucky, Coll Pharm, Lexington, KY 40536 USA
[2] Shanghai Inst Pharmaceut Ind, Ctr Drug Dev, Shanghai 200437, Peoples R China
关键词
fluoroquinolones; antibacterial agent; gram-positive bacteria;
D O I
10.1016/j.bmc.2007.08.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gram-positive organisms have re-emerged as the major hospital pathogens, which make the unmet medical needs for antibacterial therapy even worse. In searching for potent agents against Gram-positive pathogens, novel 7-(substituted)-aminomethyl-quinolone-3-carboxylic acids were designed, synthesized, and evaluated for their antibacterial activities in vitro. Many 7-monoarylaminomethyl derivatives exhibited high potency against Gram-positive organisms compared to reference agents: vancomycin and pazufloxacin. Additionally, a few 7-monoalkylaminomethyl derivatives exhibited good activities against both Gram-positive and Gram-negative organisms. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7274 / 7280
页数:7
相关论文
共 25 条
[1]   Novel antibacterial agents for the treatment of serious Gram-positive infections [J].
Abbanat, D ;
Macielag, M ;
Bush, K .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) :379-399
[2]   Development of the quinolones [J].
Andersson, MI ;
MacGowan, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 :1-11
[3]   Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria [J].
Appelbaum, PC ;
Jacobs, MR .
CURRENT OPINION IN MICROBIOLOGY, 2005, 8 (05) :510-517
[4]   MRSA - what is it and how do we deal with the problem? [J].
Barrett, JF .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (02) :253-265
[5]   Vancomycin resistance: occurrence, mechanisms and strategies to combat it [J].
Boneca, IG ;
Chiosis, G .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) :311-328
[6]   The quinolones: decades of development and use [J].
Emmerson, AM ;
Jones, AM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 :13-20
[7]   Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].
Fung-Tomc, JC ;
Minassian, B ;
Kolek, B ;
Huczko, E ;
Aleksunes, L ;
Stickle, T ;
Washo, T ;
Gradelski, E ;
Valera, L ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356
[8]   Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine [J].
Gillman, PK .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) :844-845
[9]   Fluoropuinolone resistance among Gram-positive cocci [J].
Hooper, DC .
LANCET INFECTIOUS DISEASES, 2002, 2 (09) :530-538
[10]   QUINOLONE ANTIBACTERIALS - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF CARBON ISOSTERES OF THE 1-PIPERAZINYL AND 3-AMINO-1-PYRROLIDINYL SIDE-CHAINS [J].
LABORDE, E ;
KIELY, JS ;
CULBERTSON, TP ;
LESHESKI, LE .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (14) :1964-1970